| Mr I C Martin |
Chair | |||
|---|---|---|---|---|
| Dr D G Mason | Honorary Treasurer | |||
| Mrs J Barber | ||||
| Dr P J Greaves | Honorary Treasurer (elect) | |||
| Professor TJ Hendra | ||||
| Professor Sir 8 Keogh | ||||
| Professor N Kumar |
Appointed | 4'"January 2022 | ||
| Dr 5 Lishman CBE |
||||
| Professor M Sani |
Appointed | 4'"January 2022 | ||
| The principal address ofthe charity and the registered | office ofthe company | isthe offices of NCEPOD at Abbey House, 74- | ||
| 76StJohn Street, London, EC1M 4DZ. |
| Association ofAnaesthetists | Royal College ofOphthalmologists | ||
|---|---|---|---|
| Dr W Fawcett | Vacancy | ||
| Association ofSurgeons of | Great Britain and Ireland | Royal College of Paediatrics and Child Health |
|
| Mr M Lansdown | Dr I Doughty | ||
| Royal College of Emergency | Medicine | Royal College of Physicians of London | |
| Dr A Boyle | Dr A Gibson, Dr M Kumwenda and Dr H Skene |
||
| Faculty of Dental Surgery | Royal College of Physicians and Surgeons of Glasgow |
||
| Mr J Dhanda | Dr M McKirdy —moved to observer status 4 Nov 21 | ||
| Faculty of Intensive Care Medicine |
Royal College of Physicians of Edinburgh | ||
| Dr J Butler | Dr J MacLeod —moved to observer status 4 Nov 21 | ||
| Lay Representatives | Royal College of Psychiatrists | ||
| Vacancy | Vacancy | ||
| Royal College of Anaesthetists | Royal College of Radiologists | ||
| Dr C Carey and Dr K Ramachandaran | Prof R McWilliams | ||
| Royal College of General Practitioners | Royal College of Pathologists | ||
| Vacancy | Dr L Igali | ||
| Royal College of Nursing | Royal College ofSurgeons of Edinburgh | ||
| Dr N Ashby | Miss A Paisley —moved to observer status 4 Nov 21 | ||
| Royal College ofObstetricians | and Gynaecologists | Royal College ofSurgeons of England | |
| DrT Hillard | Miss SVig |
| Twelve consultants | had been on secondment | to | NCEPOD as Clinical Co-ordinators | NCEPOD as Clinical Co-ordinators | between | 1April 2021 and | 31 March |
|---|---|---|---|---|---|---|---|
| 2022, committing | to between one and two sessions |
per week. | |||||
| Dr M Docherty | Liaison Psychiatry | ||||||
| Dr A Goodwin | Anaesthesia and Critical Care |
||||||
| Dr M Juniper | Respiratory Medicine |
||||||
| Dr K Malbon | Paediatrics | ||||||
| Dr SMcPherson | Radiology | ||||||
| Dr D McWilliams | Physiotherapy —appointed |
in March 22 | |||||
| Dr A Michalski | Paediatric Oncology |
||||||
| Mr M Sinclair | General Surgery | ||||||
| Dr V Srivastava | Acute Medicine | ||||||
| Dr ATavare | General Practice | ||||||
| Dr K Wilkinson | Paediatric Anaesthesia | —left in October 21 | |||||
| Mr J Abercrombie | Surgery |
| Area ofstudy: | Milestone reached: | |||
|---|---|---|---|---|
| Physical healthcare | in mental | health | hospitals | Report is due for release 14/4/22 |
| Epilepsy | Data being reviewed | |||
| Crohn's disease | Cases being reviewed | |||
| Community acquired |
pneumonia | Data collection just starting | ||
| Transition between |
child and | adult | healthcare | Cases being reviewed |
| Endometriosis | Study being developed | |||
| End of life care | Study being developed | |||
| Testicular torsion | Study being developed | |||
| Natural deaths in prison |
Data collection underway | |||
| Juvenile arthritis | Study being developed | |||
| Blood sodium | Study being developed | |||
| ICU rehabilitation | Study being developed |
| Year ending 31March 2 | 022 | |||
|---|---|---|---|---|
| Total | Total | |||
| Notes | 2022 | 2021 | ||
| E | E | |||
| INCOME FROM: | ||||
| Donations | 132,900 | 12,000 | ||
| Charitable activities |
1,243,871 | 1,154,353 | ||
| Investments | 6,741 | 10,303 | ||
| TOTAL INCOME | 1,383,512 | 1,176,656 | ||
| EXPENDITURE ON: | ||||
| Charitable activities |
1,216,165 | 972,248 | ||
| TOTAL EXPENDITURE | 1,216,165 | 972,248 | ||
| Net gain on investments | 11,311 | 34,820 | ||
| NET INCOME | 178,658 | 239,228 | ||
| NET MOVEMENT IN FUNDS | 178,658 | 239,228 | ||
| RECONCILIATION OF FUNDS |
||||
| Fund balances brought | forward | |||
| at 1April 2021 | 1,515,571 | 1,276,343 | ||
| FUND BALANCES CARRIED FORWARD | ||||
| AT31MARCH 2021 | 1,694,229 | 1,515,571 |
| Notes | 2022 | 2021 | ||
|---|---|---|---|---|
| f | f | |||
| FIXEDASSETS | ||||
| Tangible assets | 838 | 3,292 | ||
| Investments | 223,849 | 212,538 | ||
| 224,687 | 215,830 | |||
| CURRENT ASSETS | ||||
| Debtors | 376,339 | 355,757 | ||
| Cash at bank and in | hand | 1,264,869 | 1,091,609 | |
| 1,641,208 | 1,447,366 | |||
| LIABILITIES | ||||
| Creditors: Amounts | falling due within one year | 10 | (171,666) | (147,625) |
| NET CURRENT ASSETS | 1,469,542 | 1,299,741 | ||
| TOTAL ASSETS LESS | CURRENT LIABILITIES | |||
| & NET ASSETS | 1,694,229 | 1,515,571 | ||
| THE FUNDS OF THE | CHARITY | |||
| Unrestricted income |
funds | |||
| General Fund |
1,664,229 | 1,495,571 | ||
| Designated Premises |
Fund | 30,000 | 20,000 | |
| TOTAL CHARITY FUNDS | 1,694,229 | 1,515,571 |
| REGISTERED COMPANY N | O. 030 | 19382 | ||||
|---|---|---|---|---|---|---|
| CASH FLOWS | ||||||
| Year ending 31March 2022 | ||||||
| Notes | 2022 | 2021 | ||||
| f | E | |||||
| Cash flows from operating | activities | |||||
| Net cash provided by operating |
activities | 13 | 167,023 | 338,206 | ||
| Cash flows from investing | activities | |||||
| Interest from investments | 6,741 | 10,303 | ||||
| Purchase oftangible fixed | assets | (504) | (1,737) | |||
| Receipts from sale ofinvestments | 174,875 | |||||
| Purchase ofinvestments | (200,637) | |||||
| Net cash (outflow) inflow | from | investing | activities | 6,237 | (17,196) | |
| Increase (decrease) in cash for the year | 173,260 | 321,011 | ||||
| Cash brought forward | 1,091,609 | 770,598 | ||||
| Cash carried forward | ||||||
| 1,264,869 | 1,091,609 |
| NATIONAL CONFIDENTIAL ENQUIRY INTO PATIENT OUTCOME AND DEATH |
|---|
| REGISTERED COMPANY NO. 03019382 |
| ACCOUNTING POLICIES |
| Year ending 31March 2022 |
| O THE FINANCIAL STATE ng 31March 2022 |
MENTS | ||
|---|---|---|---|
| Total | Total | ||
| 2022 | 2021 | ||
| f | f | ||
| DONATIONS: | |||
| Donated services | 132,900 | 12,000 | |
| 132,900 | 12,000 | ||
| INCOME FROM CHARITABLE ACTIVITIES- DESIGNING AND RUNNING | CONFIDENTIAL SURVEY | ||
| Healthcare Quality Improvement |
1,207,221 | 1,091,234 | |
| Partnership (HQIP) |
|||
| Private hospitals | 30,650 | 49,800 | |
| Conference, exhibition |
and other | ||
| income sources | 6,000 | 13,319 | |
| 1,243,871 | 1,154,353 | ||
| INVESTMENT INCOME | |||
| Dividends | 6,079 | 8,161 | |
| Bank interest receivable | on | ||
| short term cash deposits | 662 | 2,142 | |
| 6,741 | 10,303 |
| Total | Total | ||||
|---|---|---|---|---|---|
| 2022 | 2021 | ||||
| f | f | ||||
| Support costs (note 5) | 241,369 | 244,142 | |||
| Direct staff costs (note | 6) | 574,354 | 515,358 | ||
| Other direct expenditure: | |||||
| Staff healthcare, training, and recruitment |
2.337 | 1,441 | |||
| Clinical co-ordinators secondments |
217,746 | 177,881 | |||
| Clinical reviewers (donated services) |
132,900 | 12,000 | |||
| Clinical co-ordinators, | reviewers, | and | |||
| staff expenses | 14,757 | 6,508 | |||
| Consultancy | 13,235 | 2,009 | |||
| Temporary staff costs |
4,696 | ||||
| Conference, exhibition, | and meetings | ||||
| expenses | 371 | (2,325) | |||
| Operating lease rentals: |
|||||
| Plant and machinery | 7,247 | 5,666 | |||
| Other printing and report production |
costs | 4,782 | 5,536 | ||
| Postage and distribution | 2,371 | 4,032 | |||
| 1,216,165 | 972,248 |
| O THE FINANCIAL STATEMENT ng 31March 2022 |
S | ||||
|---|---|---|---|---|---|
| Support | Governance | Total | Total | ||
| costs | costs | 2022 | 2021 | ||
| f | E | E | E | ||
| SUPPORT AND GOVERNANCE | COSTS | ||||
| Staff costs (note 6) | 746 | 746 | 691 | ||
| Other expenditure: | |||||
| Operating lease rentals: |
|||||
| Land and buildings | 133,644 | 133,644 | 136,747 | ||
| Other premises costs | 22,521 | 22,521 | 15,854 | ||
| Auditors' remuneration: |
|||||
| Audit fees | 8,100 | 8,100 | 10,288 | ||
| Bookkeeping and payroll costs |
9,352 | 14 | 9,366 | 11,086 | |
| Public relations | 859 | 1 | 860 | 454 | |
| Computer expenses Insurance |
21,919 20,562 |
32 30 |
21,951 20,592 |
31,127 17,635 |
|
| Sundry expenses Telephone Office costs |
6,054 4,741 8,933 |
11 7 14 |
6,065 4,748 8,947 |
4,247 4,536 5,400 |
|
| Steering Group expenses | 680 | 1 | 681 | ||
| Trustee expenses | |||||
| Depreciation —owned assets |
2,954 | 2,958 | 5,934 | ||
| Bank charges | 190 | 190 | 143 | ||
| 232,410 | 8,959 | 241,369 | 244,142 |
| PRIOR | YEAR COIVIPARATIVE | |||||
|---|---|---|---|---|---|---|
| Support | Governance | Total | Total | |||
| costs | costs | 2021 | 2020 | |||
| f | E | f | f | |||
| SUPPORT AND GOVERNANCE | COSTS | |||||
| Staff costs (note 6) | 691 | 691 | 1,490 | |||
| Other expenditure: | ||||||
| Operating lease rentals: |
||||||
| Land and buildings | 136,747 | 136,747 | 145,620 | |||
| Other premises costs | 15,854 | 15,854 | 20,810 | |||
| Auditors' remuneration: |
||||||
| Audit fees | 10,288 | 10,288 | 10,000 | |||
| Bookkeeping and payroll costs |
10,920 | 166 | 11,086 | 26,217 | ||
| Public relations | 447 | 7 | 454 | |||
| Computer expenses |
30,0660 | 467 | 31,127 | 30,111 | ||
| Insurance | 17,370 | 265 | 17,635 | 17,077 | ||
| Sundry expenses | 4,183 | 64 | 4,247 | 13,063 | ||
| Telephone | 4,468 | 68 | 4,536 | 2,832 | ||
| Office costs | 5,319 | 81 | 5,400 | 10,877 | ||
| Steering Group | 3,837 | |||||
| Trustee expenses | 3,042 | |||||
| Depreciation -owned assets |
5,849 | 85 | 5,934 | 5,640 | ||
| Bank charges | 143 | 143 | 88 | |||
| 231,960 | 12,181 | 244,142 | 290,704 |
| 2022 | 2021 | ||||
|---|---|---|---|---|---|
| STAFF COSTS | |||||
| No. | No. | ||||
| The average monthly | number ofpersons employed | by | |||
| NCEPOD during the year (excluding Trustees) was: | |||||
| Designing and running |
ofconfidential | surveys | 14 | 14 | |
| Staff costs for the above persons: | |||||
| Wages and salaries Social security costs |
480,526 47,322 |
434,049 38,975 |
|||
| Pension costs | 47,252 | 43,025 | |||
| 575,100 | 516,049 | ||||
| Staff costs are allocated in the financial statements, |
as follows: | ||||
| Designing and running Governance costs |
of confidential | surveys —unrestricted | 574,354 746 |
515,358 691 |
|
| 575,100 | 516,049 |
| Computer | Fixtures & | |||
|---|---|---|---|---|
| equipment f |
fittings f |
TOTAL f |
||
| Cost: | ||||
| 1April 2021 | 30,351 | 15,033 | 45,384 | |
| Additions | 504 | 504 | ||
| Disposals | ||||
| 31March 2022 | 30,855 | 15,033 | 45,888 | |
| Depreciation: | ||||
| 1April 2021 | 27,208 | 14,884 | 42,092 | |
| Charge in the year |
2,809 | 149 | 5,934 | |
| Depreciation on disposal |
||||
| 31March 2022 | 30,017 | 15,033 | 42,092 | |
| Net book value: | ||||
| 31March 2022 | 838 | 838 | ||
| 31March 2021 | 3,143 | 149 | 3,292 | |
| 2022 | 2021 | |||
| INVESTMENTS | ||||
| Listed investments: | ||||
| Opening balance at 1 |
April | 212,538 | 151,957 | |
| Additions at cost | 200,637 | |||
| (inc cash account movement) | ||||
| Disposals | (174,875) | |||
| Realised gains/losses | in investments | 22,918 | ||
| Unrealised gains/losses on investments |
11,311 | 11,902 | ||
| Market value at 31March | 223,849 | 212,538 |
| 2022 | 2021 | ||||
|---|---|---|---|---|---|
| Analysis ofinvestment | holdings | ||||
| QC Global income and | Growth | Fund | 223,849 | 212,538 | |
| Market value at31March | 223,849 | 212,538 | |||
| DEBTORS | |||||
| Amounts falling due within one |
year: | ||||
| Trade debtors | 304,871 | 287,351 | |||
| Other debtors | 24,643 | 25,645 | |||
| Prepayments | 46,825 | 42,761 | |||
| 376,339 | 355,757 | ||||
| 10. | CREDITORS | ||||
| Amounts falling due within one |
year: | ||||
| Trade creditors | 7,752 | 35,268 | |||
| Accruals and deferred | income | 163,914 | 112,357 | ||
| 171,666 | 147,625 | ||||
| Deferred income | |||||
| Deferred income at 1 | April 2021 | 88,000 | |||
| Resources deferred during the |
year | 22,000 | 88,000 | ||
| Amounts released from previous years |
|||||
| 110,000 | 88,000 |
| 1April | Income | Expenditure | Gain on | 31March | |||
|---|---|---|---|---|---|---|---|
| 2021 | Investment | 2022 | |||||
| f | E | f | |||||
| Unrestricted | income | funds: | |||||
| General | Fund | 1,495,571 | 1,383,512 | (1,216,165) | 11,311 | 1,664,229 | |
| Designated | Premises | 20,000 | 30,000 | ||||
| Fund | |||||||
| 1,515,571 | 1,383,512 | (1,216,165) | 11,311 | 1,694,229 |
| 1April | Income | Expenditure | Gain on | 31March | ||||
|---|---|---|---|---|---|---|---|---|
| 2020 | Investment | 2021 | ||||||
| E | E | f | ||||||
| Unrestricted | income | funds: | ||||||
| General | Fund | 1,256,343 | 1,176,656 | (972,247) | 34,820 | 1,495,571 | ||
| Designated | Premises | 20,000 | 20,000 | |||||
| Fund | ||||||||
| 1,276,343 | 1,176,656 | (972,247) | 34,820 | 1,515,571 |
| Fixed asset | Tangible fixed | Net current | Total | |||
|---|---|---|---|---|---|---|
| investments | assets | assets | ||||
| Unrestricted | income | funds: | ||||
| General Fund |
223,849 | 838 | 1,449,542 | 1,664,229 | ||
| Designated | Premises | Fund | 20,000 | 30,000 | ||
| NET ASSETS | AT31MARCH 2022 | 223,849 | 838 | 1,469,542 | 1,694,229 | |
| Fixed asset | Tangible fixed | Net current | Total | |||
| investments | assets | assets | ||||
| Unrestricted | income | funds: | ||||
| General Fund |
212,538 | 3,292 | 1,279,741 | 1,495,571 | ||
| Designated | Premises | Fund | 20,000 | 20,000 | ||
| NET ASSETS | AT31MARCH 2021 | 212,538 | 3,292 | 1,299,741 | 1,515,571 |
| 2022 | 2021 | |||
|---|---|---|---|---|
| E | E | |||
| Net income for the | year | 178,659 | 239,228 | |
| Depreciation (note |
7) | 2,959 | 5,934 | |
| (Gains) on investments | (11,311) | (34,820) | ||
| Interest from investment | (6,741) | (10,303) | ||
| Decrease (Increase) | in debtors | (20,582) | 5,639 | |
| (Decrease) increase | in creditors | 24,039 | 132,528 | |
| Net cash from operating | activities | 167,023 | 338,206 |
| At 31March 2022, NCEPOD operating leases: |
had future minimu |
m lease paymen |
ts under non-cancellabl |
e |
|---|---|---|---|---|
| 2022 | 2021 | |||
| Land & Building | Equipment | Land Ik Building | Equipment | |
| Within 1year | E69,323 | E5,606 | E142,000 | E5,606 |
| Within 2-5years | E22,424 | E71,000 | E1,402 | |
| Total | f69,323 | E28,030 | E213,000 | E7,008 |
| NET DEBT RECONCILIATION | ||||
| At 1 | April 2021 | Cash flows At 31March 2022 |
||
| E | ||||
| Cash at bank and in hand | 1,091,609 | 173,260 | 1,264,869 | |
| Debt | ||||
| Total | 1,091,609 | 173,260 | 1,264,869 | |
| ANALYSIS OF CASH AND CASH EQUIVALENTS | ||||
| 2022 | 2021 | |||
| f | E | |||
| Cash in hand | 1,264,869 | 1,091,609 | ||
| Total cash and cash equivalents | 1,264,869 | 1,091,609 |